Atlas Trials

SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)

Clinical trial NCT02258152 · COMPLETED

Trial details

NCT number
NCT02258152
Sponsor
Biotie Therapies Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease Dementia (PDD)
Start date
2014-12-22
Primary completion
2017-10-03
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.